Target intelligence / Profile preview

Endothelial cell-surface adhesion molecules (ECAMs) (ECAMs)

Target
ECAMs
Molecular classification
Receptor, Cell adhesion molecule, Immunoglobulin superfamily, Selectin family, Junctional adhesion molecule
01

Overview

Endothelial cell-surface adhesion molecules (ECAMs) represent a functional class of transmembrane proteins expressed on the vascular endothelium that facilitate the recruitment and extravasation of circulating blood cells, primarily leukocytes and platelets, into underlying tissues [1.1.1, 1.2.1]. This group includes several distinct families: the immunoglobulin superfamily (e.g., ICAM-1, VCAM-1, and PECAM-1), the selectin family (E-selectin and P-selectin), and junctional adhesion molecules (JAMs) [1.3.1, 1.3.3]. While some members are constitutively expressed at low levels, their expression is significantly upregulated by pro-inflammatory stimuli such as tumor necrosis factor-alpha (TNF-α) and interleukin-1 (IL-1), marking the transition from a quiescent to an activated endothelial state [1.1.2, 1.2.5]. These molecules are essential for the multi-step adhesion cascade, which involves leukocyte rolling (mediated by selectins), firm adhesion (mediated by ICAMs and VCAMs), and transendothelial migration (mediated by PECAM-1 and JAMs) [1.3.1, 1.3.2]. Pathological overexpression of ECAMs is a key driver in chronic inflammatory diseases, atherosclerosis, and the hematogenous metastasis of cancer cells [1.2.1, 1.2.4]. Consequently, they are major therapeutic targets; for example, crizanlizumab is a monoclonal antibody targeting P-selectin used to treat sickle cell disease, and uproleselan is an E-selectin antagonist under investigation for leukemia [1.2.1, 1.3.2]. Soluble forms of these molecules (e.g., sICAM-1, sVCAM-1) are frequently used as clinical biomarkers for endothelial dysfunction and systemic inflammation [1.3.2, 1.3.4].

Other names
Endothelial cell surface adhesion moleculesEndothelial adhesion moleculesVascular endothelial cell surface adhesion moleculesEndothelial cell-surface adhesion moleculesECAMsEndothelial cell adhesion molecules
02

Mechanism of action

Inhibition of leukocyte-endothelial cell interactions by blocking the binding of selectins or immunoglobulin-like adhesion molecules to their respective ligands on leukocytes, thereby preventing rolling, adhesion, and transmigration.

03

Biological functions

Cell adhesionImmune responseLeukocyte recruitmentInflammationSignal transduction
04

Disease associations

InflammationCardiovascular diseaseCancerInfectionSickle cell diseaseAtherosclerosisAutoimmune disease
05

Safety considerations

Increased risk of infectionImpaired immune surveillancePotential for infusion reactionsImpaired wound healingPotential for off-target effects on non-vascular tissues
06

Interacting drugs

Crizanlizumab

7 more in the full profile.

07

Biomarkers

Soluble ICAM-1 (sICAM-1)Soluble VCAM-1 (sVCAM-1)Soluble E-selectin (sE-selectin)Soluble P-selectin (sP-selectin)

Beyond the preview

Go deeper on Endothelial cell-surface adhesion molecules (ECAMs) (ECAMs).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Endothelial cell-surface adhesion molecules (ECAMs) (ECAMs).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call